Results 131 to 140 of about 6,510 (202)

Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study. [PDF]

Nat Commun
Guo Z, Wei Y, Lin G, Jia KM, Boyer C, Wang H, Li C, Hung CT, Yam CHK, Chow TY, Zhao S, Li K, Yang A, Mok CKP, Hui DS, Yeoh EK, Chong KC.   +16 more
europepmc   +1 more source

Real-world untreated risk of hospitalization and death in a nirmatrelvir/ritonavir treatment-eligible population with mild-to-moderate COVID-19 in the United States: a systematic literature review. [PDF]

BMC Infect Dis
Migliaccio-Walle K, Mugwagwa T, Cha-Silva AS, Gong CL, Campbell D, Quercia R, Bergroth T, Veenstra DL, Moran MM, Dzingina M.   +9 more
europepmc   +1 more source

A Retrospective Observational Study on COVID-19 Patients Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID). [PDF]

Pulm Ther
Murad MM, Atkin SL, Wasif PW, Behzad AA, Husain AMJA, d'Hellencourt FL, Joury J, Aziz MA, Haridy H, Spinardi J, Wang L, Boland F, Kyaw MH, Al-Qahtani M.   +13 more
europepmc   +1 more source

Real-World Effectiveness of Nirmatrelvir-Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort Study. [PDF]

Open Forum Infect Dis
Kuo RN, Chen W, Shau WY, Chang SC.
europepmc   +1 more source

Pharmacovigilance of Drug-Drug Interactions with Nirmatrelvir/Ritonavir. [PDF]

Infect Dis Ther
Hendrick V, Pohorylo E, Merchant L, Gerhart J, Arham IN, Draica F, Quercia R, Ayoub A, Mehta R.   +8 more
europepmc   +1 more source

Effectiveness of Antivirals Nirmatrelvir-Ritonavir and Molnupiravir in Viral Sepsis: Retrospective Cohort Study.

JMIR Public Health Surveill
Lee TTL, Lyu AC, Jiang TT, Chan SCL, Chan CY, Yip ETF, Luk LYF, Ho JWK, So KWL, Tsui OWK, Lam ML, Lee SY, Yamamoto T, Tong CK, Wong MS, Wong ELY, Wai AKC, Rainer TH.   +17 more
europepmc   +1 more source

Plasma concentration of voriconazole under concomitant use of nirmatrelvir/ritonavir in patients with COVID-19: a multicenter retrospective study. [PDF]

Front Pharmacol
Shi H, Zhang X, Kong Q, Yu L, Yu Z.
europepmc   +1 more source

Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19. [PDF]

Am J Kidney Dis
Contreras Nieves M, Anand S, Thomas IC, Geldsetzer P, Fung E, Tamura MK, Montez-Rath ME.   +6 more
europepmc   +1 more source

Optimized tacrolimus dosing strategy in kidney transplant recipients receiving nirmatrelvir-ritonavir for COVID-19. [PDF]

PLoS One
Yan H, Hu S, Zhang H, Zhou Y, Fu R, Xu P, Cai H, Li X, Lan G.   +8 more
europepmc   +1 more source

Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis [PDF]

Baldi, Ileana, Berti, Giacomo, Cattelan, Anna Maria, Chinellato, Gianmarco, Mazzitelli, Maria, Mengato, Daniele, Ocagli, Honoria, Venturini, Francesca   +7 more
core   +1 more source